UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 10-Q

______________

(Mark One)

☒   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarter Ended June 28, 2015

OR

☐   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from       to

 

Commission File Number 0-27460

 

(Exact name of registrant as specified in its charter)

 

Delaware (State or other jurisdiction of incorporation)   2000 Technology Parkway Newark, New York (Address of principal executive offices)

16-1387013 (I.R.S. Employer Identification No.)   14513 (Zip Code)

___________________

 

Registrant's telephone number, including area code: (315) 332-7100

_____________________________

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer: Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☐   Smaller reporting company ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of the registrant's common stock was 15,635,904, net of 3,338,307 treasury shares, as of July 29, 2015.

 

 

 

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Dollars in Thousands)
(unaudited)
ASSETS
		June 28,				December 31,
		2015				2014
Current assets:
Cash and cash equivalents		$	15,789			$	17,711
Restricted cash			143				155
Trade accounts receivable, net of allowance for doubtful accounts of $333 and $340, respectively			11,293				11,295
Inventories, net			24,000				26,086
Prepaid expenses and other current assets			1,122				1,313
Due from insurance company			184				184
Deferred income taxes			106				106
Total current assets			52,637				56,850
Property, equipment and improvements, net			9,501				9,812
Goodwill			16,427				16,407
Other intangible assets, net			4,219				4,338
Security deposits and other non-current assets			151				235
Total assets		$	82,935			$	87,642
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable		$	6,353			$	6,996
Accrued compensation and related benefits			2,388				1,725
Accrued expenses and other current liabilities			1,738				2,421
Income taxes payable			127				69
Total current liabilities			10,606				11,211
Deferred income taxes			4,572				4,462
Other non-current liabilities			56				56
Total liabilities			15,234				15,729
Commitments and contingencies (Note 10)
Shareholders' equity:
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued			—				—
Common stock – par value $.10 per share; authorized 40,000,000 shares;  issued - 18,974,211 shares at June 28, 2015 and 18,941,544 shares at December 31, 2014			1,897				1,894
Capital in excess of par value			176,249				175,940
Accumulated deficit			(95,599	)			(96,920	)
Accumulated other comprehensive loss			(401	)			(467	)
Treasury stock - at cost; 3,090,225 shares at June 28, 2015 and 1,600,731
shares at December 31, 2014			(14,307	)			(8,420	)
Total Ultralife equity			67,839				72,027
Noncontrolling interest			(138	)			(114	)
Total shareholders’ equity			67,701				71,913
Total liabilities and shareholders' equity		$	82,935			$	87,642
The accompanying notes are an integral part of these consolidated financial statements.

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
(In Thousands except per share amounts)
(unaudited)
		Three month periods ended								Six month periods ended
		June 28,				June 29,				June 28,				June 29,
		2015				2014				2015				2014
Revenues		$	18,955			$	15,199			$	38,132			$	30,484
Cost of products sold			13,096				10,987				26,266				21,937
Gross profit			5,859				4,212				11,866				8,547
Operating expenses:
Research and development			1,334				1,560				2,693				2,996
Selling, general and administrative			3,708				3,976				7,534				7,971
Total operating expenses			5,042				5,536				10,227				10,967
Operating income (loss)			817				(1,324	)			1,639				(2,420	)
Other (expense) income:
Interest income			1				—				2				9
Interest and financing expense			(65	)			(41	)			(132	)			(97	)
Miscellaneous			92				46				(30	)			30
Income (loss) from continuing operations before income taxes			845				(1,319	)			1,479				(2,478	)
Income tax provision			71				57				182				117
Net income (loss) from continuing operations			774				(1,376	)			1,297				(2,595	)
Loss from discontinued operations, net of tax			—				—				—				(61	)
Net income (loss)			774				(1,376	)			1,297				(2,656	)
Net loss attributable to non-controlling interest			14				16				24				10
Net income (loss) attributable to Ultralife			788				(1,360	)			1,321				(2,646	)
Other comprehensive income:
Foreign currency translation adjustments			44				69				66				135
Comprehensive income (loss) attributable to Ultralife		$	832			$	(1,291	)		$	1,387			$	(2,511	)
Net income (loss) per share attributable to Ultralife common shareholders – basic:
Continuing operations		$	.05			$	(.08	)		$	.08			$	(.15	)
Discontinued operations			—				—				—				(.00	)
Total		$	.05			$	(.08	)		$	.08			$	(.15	)
Net income per share attributable to Ultralife common shareholders – diluted:
Continuing operations		$	.05							$	.08
Discontinued operations			—								—
Total		$	.05							$	.08
Weighted average shares outstanding – basic			16,557				17,533				16,945				17,523
Potential common shares			40								32
Weighted average shares outstanding - diluted			16,597								16,977
The accompanying notes are an integral part of these consolidated financial statements.

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (In Thousands)
(unaudited)
		Six month periods ended
		June 28,				June 29,
		2015				2014
OPERATING ACTIVITIES:
Net income (loss)		$	1,297			$	(2,656	)
Loss from discontinued operations, net of tax			—				61
Adjustments to reconcile net income (loss) from continuing operations to net cash
provided by operating activities:
Depreciation and amortization of financing fees			1,196				1,501
Amortization of intangible assets			119				154
Stock-based compensation			304				483
Loss on long-lived asset disposals			36				—
Changes in deferred income taxes			110				110
Changes in operating assets and liabilities:
Accounts receivable			22				4,128
Inventories			2,331				(1,042	)
Prepaid expenses and other assets			193				313
Accounts payable and other liabilities			(863	)			(2,066	)
Net cash provided by operating activities			4,745				986
INVESTING ACTIVITIES:
Cash paid for property, equipment and improvements			(884	)			(398	)
Change in restricted cash			12				—
Net cash used in investing activities			(872	)			(398	)
FINANCING ACTIVITIES:
Cash paid to repurchase treasury stock			(5,887	)			(39	)
Return of security deposit			66				—
Proceeds from issuance of common stock			8				11
Net cash used in financing activities			(5,813	)			(28	)
Effect of exchange rate changes on cash and cash equivalents			18				111
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS			(1,922	)			671
Cash and cash equivalents, beginning of period			17,711				16,489
Cash and cash equivalents, end of period		$	15,789			$	17,160
NON-CASH ITEMS:
Construction in progress in accounts payable		$	—			$	790

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

ULTRALIFE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollar amounts in thousands – except share and per share amounts)

(unaudited)

 

1.

BASIS OF PRESENTATION

 

The accompanying unaudited Condensed Consolidated Financial Statements of Ultralife Corporation (the “Company”) and subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals and adjustments) considered necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Results for interim periods should not be considered indicative of results to be expected for a full year. Reference should be made to the Consolidated Financial Statements and related notes thereto contained in our Form 10-K for the year ended December 31, 2014.

 

The December 31, 2014 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.

 

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation.

 

Our quarters end on the last Sunday of the third month in the quarter, as opposed to a calendar month-based cycle for each fiscal quarter. While the actual dates for the quarter-ends will change slightly each year, we believe that there are not any material differences when making quarterly comparisons.

 

 

2.

SHARE REPURCHASE PROGRAM

 

On April 28, 2014, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”) which became effective on May 1, 2014, under which the Company was authorized to repurchase up to 1.8 million shares of its outstanding common stock over a period not to exceed twelve months.

 

On April 28, 2015, the Board of Directors authorized an extension of the Share Repurchase Program for an additional twelve month period beginning May 1, 2015 and ending April 30, 2016, subject, for the entire period as extended, to the 1.8 million share aggregate limit established in the initial authorization. 

 

On June 2, 2015, the Board of Directors approved an expansion and extension of the Share Repurchase Program, authorizing the repurchase of up to an additional 1.6 million shares through June 2, 2016.

 

Share repurchases under this program are made in accordance with SEC Rule 10b-18 using a variety of methods, which may include open market purchases, privately negotiated transactions and block trades, or any combination of such methods, in compliance with applicable insider trading and other securities laws and regulations. With the exception of repurchases made during stock trading black-out periods under a 10b5-1 Plan, the timing, manner, price and amount of any repurchase are determined at the Company’s discretion. The Share Repurchase Program may be suspended, terminated or modified by the Company at any time and for any reason.  The Share Repurchase Program does not obligate the Company to repurchase any specific number of shares.

 

 

During the three month period ended June 28, 2015, the Company repurchased 1,398,454 shares under this program for a total cost (excluding fees and commissions) of $5,509. During the six month period ended June 28, 2015, the Company repurchased 1,476,855 shares under this program for a total cost (excluding fees and commissions) of $5,805. From the inception of the Share Repurchase Program on May 1, 2014 through July 29, 2015, the Company has repurchased 1,941,691 shares for an aggregate cost (excluding fees and commissions) of $7,525. The total remaining balance of shares authorized for repurchase under the Share Repurchase Program is 1,458,309 shares as of July 29, 2015.

 

 

3.

CHINA FACILITY RELOCATION

 

During 2014, we were informed by local government authorities in Shenzhen, China that the lease for our facility there would not be extended, and we commenced a search for an alternate site to relocate our facility. In July 2014, our subsidiary in China entered into a lease for a replacement facility, also located in Shenzhen. During the fourth quarter of 2014, our subsidiary in China vacated its former facility premises and substantially completed a move and transition to this new facility.

 

The Company received compensation from the local government authorities for leasehold improvements and moving-related costs totaling $815, of which $596 was recognized as a reduction of expenses incurred during 2014, which were $841. It is the Company’s policy to recognize this compensation as a reduction of expenses as the expenses are recognized. Additional amounts totaling $158 and $219 of this government compensation were recognized as reductions of expenses during the three- and six-month periods ended June 28, 2015, respectively. The related expenses incurred during the three- and six-month periods ended June 28, 2015 were $112 and $221, respectively. The relocation payments were complete as of June 28, 2015.

 

 

4.

INVENTORIES

 

Inventories are stated at the lower of cost or market with cost determined under the first-in, first-out (FIFO) method. The composition of inventories was:

		June 28,				December 31,
		2015				2014
Raw materials		$	13,595			$	15,100
Work in process			1,814				1,489
Finished goods			8,591				9,497
Total		$	24,000			$	26,086

 

 

5.

PROPERTY, EQUIPMENT AND IMPROVEMENTS

 

Major classes of property, equipment and improvements consisted of the following:

		June 28,				December 31,
		2015				2014
Land		$	123			$	123
Buildings and leasehold improvements			7,475				7,437
Machinery and equipment			48,395				48,054
Furniture and fixtures			1,993				1,811
Computer hardware and software			4,525				4,452
Construction in process			1,390				1,351
			63,901				63,228
Less-accumulated depreciation			(54,400	)			(53,416	)
Net property, equipment and improvements		$	9,501			$	9,812

 

Depreciation expense for property, equipment and improvements was as follows:

 

		Three-month periods ended								Six-month periods ended
		June 28,				June 29,				June 28,				June 29,
		2015				2014				2015				2014
Depreciation expense		$	582			$	754			$	1,178			$	1,465

 

 

6.

GOODWILL, INTANGIBLE ASSETS AND LONG TERM ASSETS

 

a. Goodwill

 

The following table summarizes the goodwill activity by segment for the six-month periods ended June 28, 2015 and June 29, 2014:

		Battery & Energy				Communi- cations
		Products				Systems				Total
Balance - December 31, 2013		$	4,926			$	11,493			$	16,419
Effect of foreign currency translation			(16	)			—				(16	)
Balance – June 29, 2014			4,910				11,493				16,403
Effect of foreign currency translation			4				—				4
Balance - December 31, 2014			4,914				11,493				16,407
Effect of foreign currency translation			20				—				20
Balance – June 28, 2015		$	4,934			$	11,493			$	16,427

 

b. Intangible Assets

 

The composition of intangible assets was:

		at June 28, 2015
						Accumulated
		Cost				amortization				Net
Trademarks		$	3,568			$	—			$	3,568
Patents and technology			4,514				(4,184	)			330
Customer relationships			4,037				(3,738	)			299
Distributor relationships			394				(372	)			22
Total intangible assets		$	12,513			$	(8,294	)		$	4,219
			at December 31, 2014
						Accumulated
		Cost				amortization				Net
Trademarks		$	3,567			$	—			$	3,567
Patents and technology			4,509				(4,114	)			395
Customer relationships			4,029				(3,679	)			350
Distributor relationships			391				(365	)			26
Total intangible assets		$	12,496			$	(8,158	)		$	4,338

 

Amortization expense for intangible assets was as follows:

  

		Three-month periods ended								Six-month periods ended
		June 28,				June 29,				June 28,				June 29,
		2015				2014				2015				2014
Amortization included in:
Research and development		$	33			$	45			$	65			$	87
Selling, general and administrative			26				35				54				67
Total amortization expense		$	59			$	80			$	119			$	154

 

The change in the cost value of total intangible assets from December 31, 2014 to June 28, 2015 is a result of the effect of foreign currency translations.

 

 

7.

REVOLVING CREDIT AGREEMENT

 

We have financing through a Revolving Credit, Guaranty and Security Agreement, dated as of May 24, 2013, (the “Credit Agreement”) and related security agreements with PNC Bank, National Association (“PNC”), which provides a $20 million secured asset-based revolving credit facility that includes a $1 million letter of credit sub-facility (the “Credit Facility”). The Credit Agreement provides that the Credit Facility may be increased with PNC’s concurrence to an amount not to exceed $35 million, provided such increase must occur prior to the last six months of the term, which expires on May 24, 2017.

 

Our available borrowing limit under the Credit Facility is based on a borrowing base formula equal to a percentage of accounts receivable, inventory and eligible foreign in-transit inventory. Interest is payable quarterly and accrues on outstanding indebtedness under the Credit Agreement at either a LIBOR-based rate or an alternate base rate, as defined in the Credit Agreement. We pay a quarterly fee on the Credit Facility’s unused availability at 0.375% per annum.

 

As of June 28, 2015, we had approximately $11,409 of borrowing capacity in addition to our cash on hand of $15,789, and we had no outstanding borrowings or outstanding letters of credit under the Credit Facility at either June 28, 2015 or December 31, 2014.

 

On June 5, 2015, the Company and PNC entered into a Fourth Amendment to the Credit Agreement, permitting the expansion and extension of the Company’s Share Repurchase Program, described in Note 2 above, subject to the same terms and conditions set forth in the previous amendments to the Credit Agreement.

 

 

8.

SHAREHOLDERS’ EQUITY

 

We recorded non-cash stock compensation expense in each period as follows:

 

		Three-month periods ended								Six-month periods ended
		June 28,				June 29,				June 28,				June 29,
		2015				2014				2015				2014
Stock options		$	136			$	164			$	256			$	290
Restricted stock grants:
Employee			24				—				48				—
President and CEO			—				34				—				83
Board of Directors compensation –
stock grant			—				55				—				110
Total		$	160			$	253			$	304			$	483

 

These are more fully discussed as follows:

 

a. Stock Options

 

We have stock options outstanding from various stock-based employee compensation plans for which we record compensation cost relating to share-based payment transactions in our financial statements. As of June 28, 2015, there was $461 of total unrecognized compensation cost related to outstanding stock options, which is expected to be recognized over a weighted average period of 1.2 years.

 

The following table summarizes stock option activity for the six-month period ended June 28, 2015:

 

		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)				Aggregate Intrinsic Value
Outstanding at January 1, 2015			2,056,122			$	6.66
Granted			277,000				3.72
Exercised			(2,667	)			3.22
Forfeited or expired			(67,499	)			12.30
Outstanding at June 28, 2015			2,262,956				6.13				3.81			$	369
Vested and expected to vest at June 28, 2015			2,115,226				6.30				3.67			$	314
Exercisable at June 28, 2015			1,337,295			$	5.16				2.88			$	153

 

Cash received from stock option exercises under our stock-based compensation plans for the three-month periods ended June 28, 2015 and June 29, 2014 was $0 and $11, respectively. Cash received from stock option exercises for the six-month periods ended June 28, 2015 and June 29, 2014 was $9 and $11, respectively.

 

b. Restricted Stock Awards

 

Our President and Chief Executive Officer holds 60,000 unearned, unvested restricted stock units at June 28, 2015. In addition, 49,200 shares of restricted stock were awarded to certain of our employees in September, 2014. There is $82 of unrecognized compensation cost related to these restricted shares at June 28, 2015.

 

 

9.

INCOME TAXES

 

We use the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.

 

For the three-month periods ended June 28, 2015 and June 29, 2014, we recorded $71 and $57, respectively, in income tax expense. For the six-month periods ended June 28, 2015 and June 29, 2014, we recorded $182 and $117, respectively, in income tax expense. These are detailed as follows:

  

		Three-month periods ended								Six-month periods ended
		June 28,				June 29,				June 28,				June 29,
		2015				2014				2015				2014
Current income tax provision:
Foreign		$	(8	)		$	—			$	43			$	—
Federal			22				—				22				—
State			2				2				7				7
Deferred income tax provision			55				55				110				110
Total		$	71			$	57			$	182			$	117

 

Deferred income tax provision is primarily due to the recognition of deferred tax liabilities generated from goodwill and certain intangible assets that cannot be predicted to reverse for book purposes during our loss carryforward periods. The remaining expense in 2014 was due to state income taxes, and in 2015 was primarily due to the income reported for our China operations during the period.

 

Our overall effective tax rate is the result of the combination of income and losses in each of our tax jurisdictions, which is particularly influenced by the fact that we have recorded a full reserve against our deferred tax assets pertaining to cumulative historical losses for our U.S. operations and our U.K. subsidiary, as management does not believe, at this time, that it is more likely than not that we will realize the benefit of these losses. Our tax rate for the six-month period ended June 28, 2015 was 12.3%, which was different from the federal statutory rate due to the effect of the utilization of fully reserved net operating loss carryforwards (“NOL”) as well as the effect of differing foreign income tax rates, principally in China. Our tax rate for the six-month period ended June 29, 2014 was (4.7%), which was different from the federal statutory rate due to the loss incurred and our full reserve against our NOLs, and the effect of differing foreign income tax rates, principally in China.

 

We have substantial NOLs available to offset taxable income in the United States. However, we remain subject to the alternative minimum tax in the United States. The alternative minimum tax limits the amount of NOL available to offset taxable income to 90% of the current year income. We recorded a provision of $22 for U.S. alternative minimum tax for both the three and six months ended June 30, 2015, and no alternative minimum tax in either the three or six months ended June 29, 2014. The payment of the alternative minimum tax normally results in the establishment of a deferred tax asset; however, we have established a full valuation allowance for this related deferred tax asset.

 

As of June 28, 2015, we have foreign and domestic NOL and credit carryforwards totaling approximately $86,200 and $1,400 available to reduce future taxable income. Included in our NOL carryforwards are foreign loss carryforwards of approximately $12,400 that can be carried forward indefinitely. The domestic NOL carryforward of $73,800 expires from 2019 through 2035. The domestic NOL carryforward includes approximately $2,900 for which a benefit will be recorded in capital in excess of par value when realized.

 

Our unrecognized tax benefits related to uncertain tax positions at June 28, 2015 pertain to foreign tax jurisdictions. The following table summarizes the activity related to our unrecognized tax benefits:

 

		Six month periods ended
		June 28,				June 29,
		2015				2014
Balance – beginning of period		$	7,296			$	7,296
Increases related to current year tax positions			—				—
Increases related to prior year tax positions			—				—
Decreases related to prior year tax positions			—				—
Expiration of statute of limitations for assessment of taxes			—				—
Settlements of examinations			(6,778	)			—
Balance – end of period		$	518			$	7,296

 

The release of uncertain tax positions in 2015 relates to the successful conclusion of a federal tax examination, resulting in a $19.9 million increase in the amount of our reported domestic NOL carryforward.

 

We file income tax returns in various jurisdictions including U.S. federal, U.S. state and foreign jurisdictions. We are routinely subject to examination by taxing authorities in these various jurisdictions. Our U.S. tax matters for the years 2000 through 2014 remain subject to examination by the Internal Revenue Service (“IRS”) and by various state and local tax jurisdictions due to our NOL carryforwards. Our tax matters for the years 2007 through 2014 remain subject to examination by the respective foreign tax jurisdiction authorities. The IRS has now completed its examination of our 2011, 2012 and 2013 U.S. federal income tax returns, with no resulting material effect to our financial position or results of operations.

 

 

10.

EARNINGS PER SHARE

 

Basic earnings per share (“EPS”) is computed by dividing earnings attributable to the Company’s common shareholders by the weighted-average shares outstanding during the period. Diluted EPS includes the dilutive effect of securities, if any, and is calculated using the treasury stock method. For the three-month period ended June 28, 2015, 358,034 stock options and 34,200 restricted stock units were included in the calculation of Diluted EPS as such securities are dilutive. Inclusion of these securities resulted in 39,426 additional shares in the calculation of fully diluted earnings per share. For the six-month period ended June 28, 2015, 257,534 stock options and 34,200 restricted stock units were included in the calculation of Diluted EPS as such securities are dilutive. Inclusion of these securities resulted in 31,903 additional shares in the calculation of fully diluted earnings per share. Due to our net losses in both the three-month and six-month periods ended June 29, 2014, no dilutive securities were considered.

 

There were 1,904,922 and 2,271,923 outstanding stock options for the three-month periods ended June 28, 2015 and June 29, 2014, respectively, that were not included in EPS as the effect would be anti-dilutive. There were 2,005,422 and 2,271,923 outstanding stock options for the six-month periods ended June 28, 2015 and June 29, 2014, respectively, that were not included in EPS as the effect would be anti-dilutive.

 

 

11.

COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENT

a. Purchase Commitments

 

As of June 28, 2015, we have made commitments to purchase approximately $338 of production machinery and equipment.

 

b. Product Warranties

 

We estimate future costs associated with expected product failure rates, material usage and service costs in the development of our warranty obligations. Warranty reserves are based on historical experience of warranty claims and generally will be estimated as a percentage of sales over the warranty period. In the event the actual results of these items differ from the estimates, an adjustment to the warranty obligation would be recorded. Changes in our product warranty liability during the first six months of 2015 and 2014 were as follows:

 

		Six month periods ended
		June 28, 2015				June 29, 2014
Accrued warranty obligations – beginning		$	376			$	513
Accruals for warranties issued			13				66
Settlements made			(13	)			(50	)
Accrued warranty obligations – ending		$	376			$	529

 

c. Contingencies and Legal Matters

 

We are subject to legal proceedings and claims that arise from time to time in the normal course of business. We believe that the final disposition of such matters, other than the matters described below, will not have a material adverse effect on our financial position, results of operations or cash flows.

 

Dreamliner Litigation

 

In July 2013, an unoccupied Boeing 787 Dreamliner aircraft operated by Ethiopian Airlines was damaged by a fire while parked at London Heathrow Airport. We participated in and provided technical assistance in support of an investigation of this incident conducted by U.K. and U.S. regulatory authorities as well as by the manufacturer of the aircraft, as we are one of many downstream suppliers to that manufacturer.  While a final report has not been issued by the regulatory authorities, preliminary findings indicate that the fire may have been caused by circumstances related to the plane’s emergency locator transmitter (“ELT”) manufactured by another company. We continue to provide support and comment as required to the ongoing investigation.

 

On May 4, 2015, we were notified of a lawsuit in which we were named, along with other suppliers to the aircraft manufacturer, concerning that 2013 fire. The suit was filed by Ethiopian Airlines Enterprise in the Commercial Court, Queen’s Bench Division of the High Court of Justice, London. The suit seeks as damages USD 42 million plus other unspecified amounts, including those for loss of use and diminution in value of the aircraft. We maintain liability and products liability insurance through reputable providers, and in accordance with our corporate practices, immediately advised and referred this matter to our insurers. We are working with those insurers and their counsel to respond to and actively defend against this action.

 

A component of the ELT is a battery pack which incorporates Ultralife’s industry-standard lithium manganese dioxide non-rechargeable D-cell. Ultralife has had this cell in production since 2001, with millions of units produced and this cell is widely-used for global defense and commercial applications. This battery product has gone through rigorous safety and qualification testing, including United Nations Transport of Dangerous Goods, Manual of Tests and Criteria, and is authorized for use in aerospace applications under Technical Standard Order C142.

 

At this time, we believe that there is not a reasonable possibility that this incident will result in a material financial exposure to the Company.

Arista Power Litigation

 

In September 2011, we initiated an action against Arista Power, Inc. (“Arista”) and our former employee, David Modeen (“Modeen”), in the State of New York Supreme Court, County of Wayne, in which we allege that Arista recruited all but one of the members of its executive team from us, subsequently changed and redirected its business to compete directly with us by using our confidential information, and during the summer of 2011, recruited Modeen to become an Arista employee. As more fully disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014, we allege that both Arista and Modeen breached agreements with us, that Arista’s employment of Modeen will inevitably lead to the disclosure and use of our trade secrets by Arista.  We seek damages as determined at trial and preliminary and permanent injunctive relief.  The defendants answered the allegations set forth in the Complaint and asserted claims against us, which have since been dropped.  

 

We initiated the September 2011 Complaint against Arista Power to protect our shareholders, customers and employees from the unauthorized use and theft of our investments in intellectual property, trade secrets and confidential information by Arista and its employees.  Protecting our intellectual property and know-how, developed and obtained at great cost to us to form our competitive position in the marketplace and create value for our shareholders and stakeholders, is a fundamental responsibility of all our employees.

 

Discovery in this action is ongoing, and we plan to continue to pursue our complaint against Arista.  It is not possible to predict the outcome of this action, whether we will be granted the injunctive relief we seek, nor the monetary amount, if any, which we may be awarded should we prevail.

 

 

12.

BUSINESS SEGMENT INFORMATION

 

We report our results in two operating segments: Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes: lithium 9-volt, cylindrical and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories, such as cables. The Communications Systems segment includes: power supplies, cable and connector assemblies, RF amplifiers, amplified speakers, equipment mounts, case equipment, integrated communication system kits and communications and electronics systems design. We believe that reporting performance at the gross profit level is the best indicator of segment performance. As such, we report segment performance at the gross profit level and operating expenses as Corporate charges.

 

The components of segment performance were as follows:

 

Three-Month Period Ended June 28, 2015:

 

		Battery & Energy Products				Communi- cations systems				Discontinued operations				Corporate				Total
Revenues		$	15,972			$	2,983			$	—			$	—			$	18,955
Segment contribution			4,542				1,317				—				(5,042	)			817
Interest, financing
and miscellaneous
expense, net															28				28
Tax provision															(71	)			(71	)
Discontinued operations
Noncontrolling interest															14				14
Net income attributable
to Ultralife																		$	788
Total assets		$	37,084			$	27,906			$	—			$	17,945			$	82,935

 

Three-Month Period Ended June 29, 2014:

 

		Battery & Energy Products				Communi- cations systems				Discontinued operations				Corporate				Total
Revenues		$	12,165			$	3,034			$	—			$	—			$	15,199
Segment contribution			2,876				1,336				—				(5,536	)			(1,324	)
Interest, financing
and miscellaneous
expense, net															5				5
Tax provision															(57	)			(57	)
Noncontrolling interest															16				16
Net loss attributable
to Ultralife																		$	(1,360	)
Total assets		$	37,586			$	29,866			$	—			$	19,479			$	86,931

 

Six-Month Period Ended June 28, 2015:

 

		Battery & Energy Products				Communi- cations systems				Discontinued operations				Corporate				Total
Revenues		$	32,248			$	5,884			$	—			$	—			$	38,132
Segment contribution			9,326				2,540				—				(10,227	)			1,639
Interest, financing
and miscellaneous
expense, net															(160	)			(160	)
Tax provision															(182	)			(182	)
Noncontrolling interest															24				24
Net income attributable
to Ultralife																		$	1,321

 

Six-Month Period Ended June 29, 2014:

 

		Battery & Energy Products				Communi- cations systems				Discontinued operations				Corporate				Total
Revenues		$	26,087			$	4,397			$	—			$	—			$	30,484
Segment contribution			6,677				1,870				—				(10,967	)			(2,420	)
Interest, financing
and miscellaneous
expense, net															(58	)			(58	)
Tax provision															(117	)			(117	)
Discontinued operations											(61	)							(61	)
Noncontrolling interest															10				10
Net loss attributable
to Ultralife																		$	(2,646	)

 

  

13.

FAIR VALUE OF FINANCIAL INSTRUMENTS

 

FASB’s guidance for the disclosure regarding fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure regarding fair value of financial instruments approximated their carrying values at June 28, 2015 and December 31, 2014. The fair value of cash, trade accounts receivable, trade accounts payable and accrued liabilities approximates carrying value due to the short-term nature of these instruments.

 

 

14.

FIRE AT MANUFACTURING FACILITY

 

In June 2011, we experienced a fire that damaged certain inventory and machinery and equipment at our facility in China. The total amount of the loss pertaining to assets and the related expenses was approximately $1,589. We have pursued a claim against our insurance policy, with the majority of our insurance claim related to the recovery of damaged inventory. We have received payments in June 2012 and April 2013 totaling approximately $1,286 as a partial payment on our insurance claim, which resulted in no gain or loss being recognized. As of June 28, 2015 and December 31, 2014, we reflect a receivable from the insurance company relating to this claim of $184, which is net of our deductible of approximately $132, and represents additional proceeds expected to be received.

 

15.

RECENT ACCOUNTING PRONOUNCEMENTS AND DEVELOPMENTS

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers.”  This ASU amends the existing accounting standards for revenue recognition and is based on the principle that revenue should be recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration a company expects to receive in exchange for those goods or services.  In April 2015, the FASB proposed a one year delay in the effective date of ASU 2014-09. This standard currently becomes effective for the Company on January 1, 2017, and the one-year delay, if promulgated as proposed, will make this standard effective for the Company on January 1, 2018. The Company is currently evaluating the potential impact of this new guidance as well as the available transition methods.

 

 

 

 

 

 

 

 

 

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. This report contains certain forward-looking statements and information that are based on the beliefs of management as well as assumptions made by and information currently available to management. The statements contained in this report relating to matters that are not historical facts are forward-looking statements that involve risks and uncertainties, including, but not limited to, our reliance on a certain key customer; possible reduced or further delayed U.S. and foreign defense spending, including the uncertainty of government budget approvals; possible delays or lack of success in our efforts to develop new commercial applications for our products; possible declines in demand for products using our batteries or communications systems; general domestic and global economic conditions; variability in our quarterly and annual results and price of our common stock; the unique risks associated with our Chinese operations; the possibility of impairment of our intangible assets; potential breaches in security and other disruptions; the possibility that our resources could be overwhelmed by our growth prospects; residual effects of negative news related to our industries; potential significant costs from our warranties; loss of top management; possible disruptions in our supply of raw materials and components; failure of customers to meet the volume expectations in our supply agreements; our inability to adequately protect our proprietary and intellectual property; the possibility that our ability to use our NOL carryforwards in the future may be limited; possible adverse effects from violations of the U.S. Foreign Corrupt Practices Act and other anti-corruption laws; variability of foreign currencies; the process of U.S. defense procurement; possible effects of audits of our contracts by the U.S. and foreign governments; our compliance with the regulations for the shipment of our products; business disruptions and other safety risks including those caused by fires; government and environmental regulations; and other risks and uncertainties, certain of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those forward-looking statements described herein. When used in this report, the words “anticipate”, “believe”, “estimate” or “expect” or words of similar import are intended to identify forward-looking statements. For further discussion of certain of the matters described above and other risks and uncertainties, see Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014.

 

Undue reliance should not be placed on our forward-looking statements. Except as required by law, we disclaim any obligation to update any risk factors or to publicly announce the results of any revisions to any of the forward-looking statements contained in this Quarterly Report on Form 10-Q or our Annual Report on Form 10-K for the year ended December 31, 2014 to reflect new information or risks, future events or other developments.

 

The following discussion and analysis should be read in conjunction with the accompanying Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this Form 10-Q and the Risk Factors and our Consolidated Financial Statements and Notes thereto contained in our Form 10-K for the year ended December 31, 2014.

 

The financial information in this Management’s Discussion and Analysis of Financial Condition and Results of Operations is presented in thousands of dollars, except for share and per share amounts. All figures presented below represent results from continuing operations, unless otherwise specified.

 

General

 

We offer products and services ranging from power solutions to communications and electronics systems. Through our engineering and collaborative approach to problem solving, we serve government, defense and commercial customers across the globe. We design, manufacture, install and maintain power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories and custom engineered systems. We continually evaluate ways to grow and broaden the scope of our products and services, including the design, development and sale of new products, expansion of our sales force to penetrate new markets and geographies, as well as seeking opportunities to expand through acquisitions. We sell our products worldwide through a variety of trade channels, including original equipment manufacturers (“OEMs”), industrial and defense supply distributors and directly to U.S. and international defense departments.

 

We report our results in two operating segments: Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes lithium 9-volt, cylindrical and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories, such as cables. The Communications Systems segment includes RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems kits and communications and electronics systems design. We believe that reporting performance at the gross profit level is the best indicator of segment performance.  As such, we report segment performance at the gross profit level and operating expenses as Corporate charges. (See Note 12 in the Notes to Consolidated Financial Statements)

 

 

 

 

 

Overview

 

Consolidated revenues of $18,955 for the three-month period ended June 28, 2015, increased by $3,756 or 24.7%, from $15,199 during the three-month period ended June 29, 2014, due primarily to increased orders from U.S. government and defense customers for our Battery & Energy Products business.

 

Gross profit for the three-month period ended June 28, 2015 was $5,859, or 30.9% of revenues, compared to $4,212, or 27.7% of revenues, for the same quarter a year ago. The 320 basis points improvement is due primarily to favorable product mix, higher production volume increasing the absorption of factory overhead and continued productivity improvements.

 

Operating expenses decreased to $5,042 during the three-month period ended June 28, 2015, compared to $5,536 during the three-month period ended June 29, 2014, resulting primarily from continued actions to reduce discretionary spending while focusing on the development of new products and revenue growth.

 

The increased revenue and resulting leverage on gross profit along with lower operating expenses resulted in an operating profit of $817 for the three-month period ended June 28, 2015, compared to an operating loss of $1,324 for the three-month period ended June 29, 2014. The year-over-year improvement in operating profit of $2,141 resulted from the 24.7% increase in sales that contributed $1,041 to the improvement of operating profit, the 320 basis point improvement in gross margin which contributed $606 and the lower operating expenses which contributed $494.

 

Net income was $774, or $0.05 per share, for the three-month period ended June 28, 2015, compared to a net loss of $(1,376), or $(0.08) per share, for the three-month period ended June 29, 2014.

 

Adjusted EBITDA from continuing operations, defined as net income (loss) attributable to Ultralife before net interest expense, provision (benefit) for income taxes, depreciation and amortization, amounted to $1,725 in the second quarter of 2015 compared to $(174) in the second quarter of 2014. See the section “Adjusted EBITDA from continuing operations” beginning on Page 22 for a reconciliation of Adjusted EBITDA from continuing operations to net income (loss) attributable to Ultralife.

 

As a result of careful working capital management and cash generated from operations, our liquidity remains solid with no debt, and cash and cash equivalents of $15,789, a $1,922 or 10.9% decrease from our cash position of $17,711 at December 31, 2014. The decrease in cash and cash equivalents from year-end 2014 is primarily attributable to our purchases of stock under our Share Repurchase Program which totaled $5,849 inclusive of fees and commissions related to such purchases, partially offset by cash generated from our operating results and an 8.0% inventory reduction.

 

At the mid-point of the year with revenue growth of 25.1% and EPS improvement of $0.23 over the first half of 2014, we have increasing confidence in our outlook for top-line growth and profitable results in 2015.

 

 

Results of Operations

 

Three-month periods ended June 28, 2015 and June 29, 2014

 

Revenues. Consolidated revenues for the three-month period ended June 28, 2015 amounted to $18,955, an increase of $3,756, or 24.7%, from the $15,199 reported for the three-month period ended June 29, 2014.

 

Battery & Energy Products revenues increased $3,807, or 31.3%, from $12,165 for the three-month period ended June 29, 2014 to $15,972 for the three-month period ended June 28, 2015. The increase was primarily attributable to higher shipments of batteries to U.S. government and defense customers, which helped to increase government and defense shipments by 94.1% over the 2014 period, and now comprise 42% of total Battery & Energy Products sales versus 28% for the second quarter of 2014. Commercial revenues for the second quarter of 2015 increased 6.7% over the year-earlier period due to higher shipments of 9-Volt batteries to large global smoke detector OEM’s and rechargeable batteries into medical channels.

 

Communications Systems revenues decreased $51, or 1.7%, from $3,034 in the three-month period ended June 29, 2014 to $2,983 for the three-month period ended June 28, 2015. The second quarter of 2014 benefitted from the fulfillment of a $1,895 order for Universal Vehicle Adaptors shortly after its market launch. Nevertheless, for the 2015 period, we experienced more broad-based sales as well as increases in our order flow reflecting increased demand from system integrators in support of U.S. Department of Defense program and international projects.

 

Cost of Products Sold. Cost of products sold totaled $13,096 for the quarter ended June 28, 2015, an increase of $2,109, or 19.2%%, from the $10,987 reported for the same quarter a year ago. Consolidated cost of products sold as a percentage of total revenue decreased from 72.3% for the three-month period ended June 29, 2014 to 69.1% for the three-month period ended June 28, 2015. Correspondingly, consolidated gross margin was 30.9% for the three-month period ended June 28, 2015, compared with 27.7% for the three-month period ended June 29, 2014, reflecting favorable product mix, higher production volume increasing the absorption of factory overhead and continued productivity improvements.

 

In our Battery & Energy Products segment, the cost of products sold increased $2,141, from $9,289 during the three-month period ended June 29, 2014 to $11,430 during the three-month period ended June 28, 2015. Battery & Energy Products’ gross profit for the second quarter of 2015 was $4,542, or 28.4% of revenues, an increase of $1,666 from gross profit of $2,876, or 23.6% of revenues, for the second quarter of 2014. Battery & Energy Products’ gross margin as a percentage of revenues increased for the three-month period ended June 28, 2015 by 480 basis points, reflecting favorable mix, higher production volume and ongoing productivity improvements through the Lean process.

 

In our Communications Systems segment, the cost of products sold decreased by $32 or 1.9% from $1,698 during the three-month period ended June 29, 2014 to $1,666 during the three-month period ended June 28, 2015. Communications Systems’ gross profit for the second quarter of 2015 was $1,317, or 44.2% of revenues, a decrease of $19 from gross profit of $1,336, or 44.0% of revenues, for the second quarter of 2014. The 20 basis points increase in gross margin as a percentage of revenue during 2015 is driven primarily by product mix.

 

Operating Expenses. Operating expenses for the three-month period ended June 28, 2015 totaled $5,042, a decrease of $494 or 8.9% from the $5,536 recorded during the three-month period ended June 290, 2014, resulting primarily from continued tight control over all discretionary spending.

 

Overall, operating expenses as a percentage of revenues were 26.6% for the quarter ended June 28, 2015 compared to 36.4% for the quarter ended June 29, 2014. Amortization expense associated with intangible assets related to our acquisitions was $59 for the second quarter of 2015 ($26 in selling, general and administrative expenses and $33 in research and development costs), compared with $80 for the second quarter of 2014 ($35 in selling, general, and administrative expenses and $45 in research and development costs). Research and development costs were $1,334 for the three-month period ended June 28, 2015, a decrease of $226, or 14.5%, from $1,560 for the three-months ended June 29, 2014, as we continued to focus our spending on the development of new products with the highest estimated return on investment. Selling, general, and administrative expenses decreased $268, or 6.7%, to $3,708 during the second quarter of 2015 from $3,976 during the second quarter of 2014, reflecting continued actions to reduce discretionary expenses.

 

Other Income (Expense). Other income (expense) totaled $28 for the three-month period ended June 28, 2015 compared to $5 for the three-month period ended June 29, 2014. Interest and financing expense, net of interest income, increased $23, to $64 for the second quarter of 2015 from $41 for the comparable period in 2014, as a result of costs to insure certain non-U.S. accounts receivable consistent with our Credit Agreement with PNC Bank. Miscellaneous income (expense) amounted to $92 for the second quarter of 2015 compared with $46 for the second quarter of 2014, primarily due to transactions impacted by changes in foreign currencies relative to the U.S. dollar.

 

Income Taxes. We reflected a tax provision of $71 for the second quarter of 2015, an increase of $14 as compared to the $57 provision reported for the second quarter of 2014, primarily as a result of estimated U.S. federal minimum taxes.

 

See Note 9 in the Notes to Condensed Consolidated Financial Statements for additional information regarding our income taxes.

 

Certain of our NOL carryforwards are subject to U.S. alternative minimum tax such that carryforwards can offset only 90% of alternative minimum taxable income. This limitation resulted in an estimated minimum income tax provision for the second quarter of 2015 but did not have an impact on income taxes determined for the second quarter of 2014. The use of our U.K. NOL carryforwards may be limited due to the change in the U.K. operation during 2008 from a manufacturing and assembly center to primarily a distribution and service center and its subsequent change to a sales center in 2012.

 

Net Income (Loss) Attributable to Ultralife. Net income (loss) attributable to Ultralife and income (loss) attributable to Ultralife common shareholders per diluted share was $788 and $0.05, respectively, for the three months ended June 28, 2015, compared to ($1,360) and $(0.08), respectively, for the three months ended June 29, 2014. Average common shares outstanding used to compute diluted earnings per share decreased from 17,533,000 in the second quarter of 2014 to 16,597,000 in the second quarter of 2015 due to the repurchase of stock under our Share Repurchase Plan.

 

Six-month periods ended June 28, 2015 and June 29, 2014

 

Revenues. Consolidated revenues for the six-month period ended June 28, 2015 amounted to $38,132, an increase of $7,648 or 25.1%, from the $30,484 reported for the six-month period ended June 29, 2014.

 

Battery & Energy Products revenues increased $6,161, or 23.6%, from $26,087 for the six-month period ended June 29, 2014 to $32,248 for the six-month period ended June 28, 2015. Government and defense sales of this business increased 63.8% over the 2014 six-month period and now comprise 45.8% of total segment sales versus 34.5% last year. The year-over-year growth was driven by higher shipments of batteries and chargers to a large international prime defense supplier and shipments of primary batteries to the U.S. Government’s Defense Logistics Agency. Commercial sales increased 2.4% over the 2014 period reflecting higher shipments of 9-Volt batteries to global smoke-detector OEM’s and rechargeable batteries into medical channels.

 

Communications Systems revenues increased $1,487, or 33.8%, from $4,397 during the six-month period ended June 29, 2014 to $5,884 for the six-month period ended June 28, 2015, reflecting increased demand from system integrators in support of U.S. Department of Defense programs and international projects.

 

 

Cost of Products Sold. Cost of products sold totaled $26,266 for the six-month period ended June 28, 2015, an increase of $4,329, or 19.7%, from the $21,937 reported for the same six-month period a year ago. Consolidated cost of products sold as a percentage of total revenue decreased from 72.0% for the six-month period ended June 29, 2014 to 68.9% for the six-month period ended June 28, 2015. Correspondingly, consolidated gross margin was 31.1% for the six-month period ended June 28, 2015, compared with 28.0% for the six-month period ended June 29, 2014, reflecting favorable product mix, higher production volume increasing the absorption of factory overhead and continued productivity improvements through the Company’s Lean process.

 

For our Battery & Energy Products segment, the cost of products sold increased $3,512, from $19,410 during the six-month period ended June 29, 2014 to $22,922 during the six-month period ended June 28, 2015. Battery & Energy Products’ gross profit for the 2015 six-month period was $9,326, or 28.9% of revenues, an increase of $2,649 from gross profit of $6,677, or 25.6% of revenues, for the 2014 six-month period. Battery & Energy Products’ gross margin as a percentage of revenues increased for the six-month period ended June 28, 2015 by 330 basis points, reflecting favorable mix, higher production volumes and ongoing productivity improvements through the Lean process.

 

For our Communications Systems segment, the cost of products sold increased by $817 or 32.3% from $2,527 during the six-month period ended June 29, 2014 to $3,344 during the six-month period ended June 28, 2015. Communications Systems’ gross profit for the first six months of 2015 was $2,540, or 43.2% of revenues, an increase of $670 from gross profit of $1,870, or 42.5% of revenues, for the second quarter of 2014. The 70 basis points increase in gross margin as a percentage of revenue during 2015 is due to a greater mix of higher-margin new products and increased manufacturing throughput.

 

Operating Expenses. Total operating expenses for the six-month period ended June 28, 2015 totaled $10,227, a decrease of $740 or 6.7% from the $10,967 recorded during the six-month period ended June 29, 2014, resulting primarily from continued tight control over all discretionary spending.

 

Overall, operating expenses as a percentage of revenues were 26.8% for the six-month period ended June 28, 2015 compared to 36.0% for the comparable 2014 period. Amortization expense associated with intangible assets related to our acquisitions was $119 for the first six months of 2015 ($54 in selling, general and administrative expenses and $65 in research and development costs), compared with $154 for the first six months of 2014 ($67 in selling, general, and administrative expenses and $87 in research and development costs). Research and development costs were $2,693 for the six-month period ended June 28, 2015, a decrease of $303, or 10.1%, from $2,996 for the six-months ended June 29, 2014, as we continued to focus our spending on the development of new products with the highest estimated return on investment. Selling, general, and administrative expenses decreased $437, or 5.5%, from $7,971 during the first six months of 2014 to $7,534 during the first six months of 2015, reflecting continued actions to reduce discretionary general and administrative expenses.

 

Other Income (Expense). Other (expense) totaled $(160) for the six-month period ended June 28, 2015 compared to $(58) for the three-month period ended June 29, 2014. Interest and financing expense, net of interest income, increased $42, to $130 for the 2015 period from $88 for the comparable period in 2014, as a result of costs to insure certain non-U.S. accounts receivable consistent withour Credit Agreement with PNC Bank. Miscellaneous income (expense) amounted to ($30) for the first six months of 2015 compared with $30 for the first six months of 2014, primarily due to transactions impacted by changes in foreign currencies relative to the U.S. dollar.

 

Income Taxes. We reflected a tax provision of $182 for the first two quarters of 2015 compared with a tax provision of $117 for the first two quarters of 2014. The increase of $65, or 55.6% was due to estimated U.S. minimum taxes in 2015 and increased foreign tax liabilities. The effective consolidated tax rate for the six-month periods ended June 28, 2015 and June 29, 2014 were:

 

 

		Six-month periods ended
		June 28,				June 29,
		2015				2014
Income (loss) income from continuing operations before
income taxes (a)		$	1,479			$	(2,478	)
Income tax provision (b)			182				117
Effective income tax rate (b/a)			12.3	%			(4.7	)%

 

See Note 9 in the Notes to Condensed Consolidated Financial Statements for additional information regarding our income taxes.

 

Discontinued Operations. Income (Loss) from discontinued operations, net of tax, totaled $0 for the first six months of 2015, compared to ($61) for the comparable period in 2014. The loss for the 2014 period reflects the final settlement of the sale of our RedBlack business.

 

Net Income (Loss) Attributable to Ultralife. Net income (loss) attributable to Ultralife and income (loss) attributable to Ultralife common shareholders per diluted share was $1,321 and $0.08, respectively, for the six months ended June 28, 2015, compared to $($2,656) and $(0.15), respectively, for the six months ended June 29, 2014. Average common shares outstanding used to compute diluted earnings per share decreased from 17,523,000 in the 2014 period to 16,977,000 in the 2015 period, mainly due to the repurchase of stock under our Share Repurchase Plan, stock option exercises, vesting of restricted stock units and shares of common stock issued to our non-employee directors.

 

Adjusted EBITDA from Continuing Operations

 

In evaluating our business, we consider and use Adjusted EBITDA from continuing operations, a non-GAAP financial measure, as a supplemental measure of our operating performance. We define Adjusted EBITDA from continuing operations as net income (loss) attributable to Ultralife before net interest expense, provision (benefit) for income taxes, depreciation and amortization, plus/minus expenses/income that we do not consider reflective of our ongoing continuing operations. We use Adjusted EBITDA from continuing operations as a supplemental measure to review and assess our operating performance and to enhance comparability between periods. We also believe the use of Adjusted EBITDA from continuing operations facilitates investors’ use of operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in such items as capital structures (affecting relative interest expense and stock-based compensation expense), the book amortization of intangible assets (affecting relative amortization expense), the age and book value of facilities and equipment (affecting relative depreciation expense) and other significant non-operating expenses or income. We also present Adjusted EBITDA from continuing operations because we believe it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. We reconcile Adjusted EBITDA from continuing operations to net income (loss) attributable to Ultralife, the most comparable financial measure under U.S. generally accepted accounting principles (“U.S. GAAP”).

 

We use Adjusted EBITDA from continuing operations in our decision-making processes relating to the operation of our business together with U.S. GAAP financial measures such as income (loss) from operations. We believe that Adjusted EBITDA from continuing operations permits a comparative assessment of our operating performance, relative to our performance based on our U.S. GAAP results, while isolating the effects of depreciation and amortization, which may vary from period to period without any correlation to underlying operating performance, and of non-cash stock-based compensation, which is a non-cash expense that varies widely among companies. We believe that by limiting Adjusted EBITDA to continuing operations, we assist investors in gaining a better understanding of our business on a going forward basis. We provide information relating to our Adjusted EBITDA from continuing operations so that securities analysts, investors and other interested parties have the same data that we employ in assessing our overall operations. We believe that trends in our Adjusted EBITDA from continuing operations are a valuable indicator of our operating performance on a consolidated basis and of our ability to produce operating cash flows to fund working capital needs, to service debt obligations and to fund capital expenditures.

 

The term Adjusted EBITDA from continuing operations is not defined under U.S. GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with U.S. GAAP. Our Adjusted EBITDA from continuing operations has limitations as an analytical tool, and when assessing our operating performance, Adjusted EBITDA from continuing operations should not be considered in isolation or as a substitute for net income (loss) attributable to Ultralife or other consolidated statement of operations data prepared in accordance with U.S. GAAP. Some of these limitations include, but are not limited to, the following:

 

·

Adjusted EBITDA from continuing operations does not reflect (1) our cash expenditures or future requirements for capital expenditures or contractual commitments; (2) changes in, or cash requirements for, our working capital needs; (3) the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; (4) income taxes or the cash requirements for any tax payments; and (5) all of the costs associated with operating our business;

 

·

although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA from continuing operations does not reflect any cash requirements for such replacements;

 

·

while stock-based compensation is a component of cost of products sold and operating expenses, the impact on our consolidated financial statements compared to other companies can vary significantly due to such factors as assumed life of the stock-based awards and assumed volatility of our common stock;

 

·

although discontinued operations does not reflect our current business operations, discontinued operations includes the costs we incurred by exiting our Energy Services and certain of our UK businesses and divesting our RedBlack Communications business; and

 

·

other companies may calculate Adjusted EBITDA from continuing operations differently than we do, limiting its usefulness as a comparative measure.

 

We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA from continuing operations only supplementally. Adjusted EBITDA from continuing operations is calculated as follows for the periods presented:

 

		Three-month periods ended								Six-month periods ended
		June 28,				June 29,				June 28,				June 29,
		2015				2014				2015				2014
Net income (loss) attributable to Ultralife		$	788			$	(1,360	)		$	1,321			$	(2,646	)
Add (subtract):
Interest and financing expense, net			65				41				132				97
Income tax provision			71				57				182				117
Depreciation expense			582				754				1,178				1,465
Amortization of intangible assets			59				80				119				154
Stock-based compensation expense			160				254				304				483
Impairment of long-lived assets			—				—				36				—
Loss (gain) from discontinued operations			—				—				—				61
Adjusted EBITDA		$	1,725			$	(174	)		$	3,272			$	(269	)

 

Liquidity and Capital Resources

 

As of June 28, 2015, cash and cash equivalents totaled $15,789, a decrease of $1,922 from the beginning of the year. During the six-month period ended June 28, 2015, we generated $4,745 of cash from our operating activities as compared to cash generated totaling $986 during the six-month period ended June 29, 2014. Cash generated from operations in 2015 included our net income of $1,297 plus non-cash expenses (depreciation, amortization and stock-based compensation) totaling $1,655, and cash provided by a $2,331 decrease in inventories, offset partially by a decrease in accounts payable and other liabilities of $863. Cash generated from operations in 2014 was positive despite our net loss of $2,656, as the loss was largely offset by non-cash expenses totaling $2,178. Cash generated from operations in 2014 resulted primarily from a $4,128 decrease in accounts receivable, offset partially by our loss of $2,656, a decrease in accounts payable and other liabilities of $2,106 and an increase in inventories which totaled $1,042.

 

Inventory turnover for the first six months of 2015 was an annualized rate of approximately 1.9 turns per year, a slight improvement over the 1.8 figure from the first six months of 2014.

 

We used $872 in cash for investing activities during the six month period ended June 28, 2015 compared with $398 in cash used for investing activities in the same period in 2014. In both periods, this spending was principally for the purchase of property, equipment and improvements.

 

As of June 28, 2015, we had made commitments to purchase approximately $338 of production machinery and equipment, which we expect to fund through operating cash flows or debt borrowings.

 

On April 28, 2014, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”) which became effective on May 1, 2014, under which the Company was authorized to repurchase up to 1.8 million shares of its outstanding common stock over a period not to exceed twelve months.

 

On April 28, 2015, the Board of Directors authorized an extension of the Share Repurchase Program for an additional twelve month period beginning May 1, 2015 and ending April 30, 2016, subject, for the entire period as extended, to the 1.8 million share aggregate limit established in the initial authorization. 

 

On June 2, 2015, the Board of Directors approved an expansion and extension of the Share Repurchase Program, authorizing the repurchase of up to an additional 1.6 million shares through June 2, 2016.

 

Share repurchases under this program are made in accordance with SEC Rule 10b-18 using a variety of methods, which may include open market purchases, privately negotiated transactions and block trades, or any combination of such methods, in compliance with applicable insider trading and other securities laws and regulations. With the exception of repurchases made during stock trading black-out periods under a 10b5-1 Plan, the timing, manner, price and amount of any repurchase are determined at the Company’s discretion. The Share Repurchase Program may be suspended, terminated or modified by the Company at any time and for any reason.  The Share Repurchase Program does not obligate the Company to repurchase any specific number of shares.

 

During the three month period ended June 28, 2015, the Company repurchased 1,398,454 shares under this program for a total cost (excluding fees and commissions) of $5,509. During the six month period ended June 28, 2015, the Company repurchased 1,476,855 shares under this program for a total cost (excluding fees and commissions) of $5,805. From the inception of the Share Repurchase Program on May 1, 2014 through July 29, 2015, the Company has repurchased 1,941,691 shares for an aggregate cost (excluding fees and commissions) of $7,525. The total remaining balance of shares authorized for repurchase under the Share Repurchase Program is 1,458,309 shares as of July 29, 2015.

 

 

Debt Commitments

 

We have financing through our Credit Facility with PNC Bank, which provides a $20 million secured asset-based revolving credit facility that includes a $1 million letter of credit sub-facility. As of June 28, 2015, we had approximately $11,409 of borrowing capacity under our $20 million Credit Facility with PNC Bank, in addition to our cash on hand of $15,789, and we had no outstanding borrowings or outstanding letters of credit under the Credit Facility at either June 28, 2015 or June 29, 2014.

 

Our available borrowing limit under the Credit Facility is based on a borrowing base formula equal to a percentage of accounts receivable, inventory and eligible foreign in-transit inventory. Interest is payable quarterly and accrues on outstanding indebtedness under the Credit Agreement at either a LIBOR-based rate or an alternate base rate, as defined in the Credit Agreement. We pay a quarterly fee on the Credit Facility’s unused availability at 0.375% per annum.

  

Other Matters

 

During 2014, we were informed by local government authorities in Shenzhen, China that the lease for our facility there would not be extended, and we commenced a search for an alternate site to relocate our facility. In July 2014, our subsidiary in China entered into a lease for a replacement facility, also located in Shenzhen. During the fourth quarter of 2014, our subsidiary in China vacated its former facility premises and substantially completed a move and transition to this new facility.

 

The Company received compensation from the local government authorities for leasehold improvements and moving-related costs totaling $815, of which $596 was recognized as a reduction of expenses incurred during 2014, which were $841. It is the Company’s policy to recognize this compensation as a reduction of expenses as the expenses are recognized. An additional $158 and $61 of this government compensation were recognized as reductions of expenses during the three and six month periods ended June 28, 2015, respectively. The related expenses incurred during the three and six month periods ended June 28, 2015 were $103 and $212, respectively. The relocation payments were complete as of June 28, 2015.

  

With respect to our battery products, we typically offer warranties against any defects due to product malfunction or workmanship for a period up to one year from the date of purchase. With respect to our communications accessory products, we typically offer a three-year warranty. We provide for a reserve for these potential warranty expenses, which is based on an analysis of historical warranty issues. There is no assurance that future warranty claims will be consistent with past history, and in the event we experience a significant increase in warranty claims, there is no assurance that our reserves would be sufficient. This could have a material adverse effect on our business, financial condition and results of operations.

 

Critical Accounting Policies

 

Management exercises judgment in making important decisions pertaining to choosing and applying accounting policies and methodologies in many areas. Not only are these decisions necessary to comply with U.S. GAAP, but they also reflect management’s view of the most appropriate manner in which to record and report our overall financial performance. All accounting policies are important, and all policies described in Note 1 (“Summary of Operations and Significant Accounting Policies”) to our Consolidated Financial Statements in our 2014 Annual Report on Form 10-K should be reviewed for a greater understanding of how our financial performance is recorded and reported.

 

During the first six months of 2015, there were no significant changes in the manner in which our significant accounting policies were applied or in which related assumptions and estimates were developed.

 

 

ITEM 4. Controls and Procedures

 

Evaluation Of Disclosure Controls And Procedures

 

Our President and Chief Executive Officer (Principal Executive Officer) and our Chief Financial Officer and Treasurer (Principal Financial Officer) have evaluated our disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15(e)) as of the end of the period covered by this quarterly report. Based on this evaluation, our President and Chief Executive Officer and Chief Financial Officer and Treasurer concluded that our disclosure controls and procedures were effective as of such date.

 

Changes In Internal Control Over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Securities Exchange Act Rule 13a-15(f)) that occurred during the fiscal quarter covered by this quarterly report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

  

 

PART II OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Dreamliner Litigation

 

In July 2013, an unoccupied Boeing 787 Dreamliner aircraft operated by Ethiopian Airlines was damaged by a fire while parked at London Heathrow Airport. We participated in and provided technical assistance in support of an investigation of this incident conducted by UK and US regulatory authorities as well as by the manufacturer of the aircraft, as we are one of many downstream suppliers to that manufacturer.  While a final report has not been issued by the regulatory authorities, preliminary findings indicate that the fire may have been caused by circumstances related to the plane’s emergency locator transmitter (ELT) manufactured by another company. We continue to provide support and comment as required to the ongoing investigation.

 

On May 4, 2015, we were notified of a lawsuit in which we were named, along with other suppliers to the aircraft manufacturer, concerning that 2013 fire. The suit was filed by Ethiopian Airlines Enterprise in the Commercial Court, Queen’s Bench Division of the High Court of Justice, London. The suit seeks as damages USD 42 million plus other unspecified amounts, including those for loss of use and diminution in value of the aircraft. We maintain liability and products liability insurance through reputable providers, and in accordance with our corporate practices, immediately advised and referred this matter to our insurers. We are working with those insurers and their counsel to respond to and actively defend against this action.

 

A component of the ELT is a battery pack which incorporates Ultralife’s industry-standard lithium manganese dioxide non-rechargeable D-cell. Ultralife has had this cell in production since 2001, with millions of units produced and this cell is widely-used for global defense and commercial applications. This battery product has gone through rigorous safety and qualification testing, including United Nations Transport of Dangerous Goods, Manual of Tests and Criteria, and is authorized for use in aerospace applications under Technical Standard Order C142.

 

At this time, we believe that there is not a reasonable possibility that this incident will result in a material financial exposure to the Company.

 

Arista Power Litigation

 

In September 2011, we initiated an action against Arista Power, Inc. (“Arista”) and our former employee, David Modeen (“Modeen”), in the State of New York Supreme Court, County of Wayne, in which we allege that Arista recruited all but one of the members of its executive team from us, subsequently changed and redirected its business to compete directly with us by using our confidential information, and during the summer of 2011, recruited Modeen to become an Arista employee. As more fully disclosed in our Annual Report on Form 10-K, we allege that both Arista and Modeen breached agreements with us, that Arista’s employment of Modeen will inevitably lead to the disclosure and use of our trade secrets by Arista.  We seek damages as determined at trial and preliminary and permanent injunctive relief.  The defendants answered the allegations set forth in the Complaint and asserted claims against us, which have since been dropped.  

 

We initiated the September 2011 Complaint against Arista Power to protect our shareholders, customers and employees from the unauthorized use and theft of our investments in intellectual property, trade secrets and confidential information by Arista and its employees.  Protecting our intellectual property and know-how, developed and obtained at great cost to us to form our competitive position in the marketplace and create value for our shareholders and stakeholders, is a fundamental responsibility of all our employees.

 

Discovery in this action is ongoing, and we plan to continue to pursue our complaint against Arista.  It is not possible to predict the outcome of this action, whether we will be granted the injunctive relief we seek, nor the monetary amount, if any, which we may be awarded should we prevail.

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

2(c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers 

The following table sets forth information regarding second quarter 2015 purchases of common stock under the Company’s stock repurchase program. Under the repurchase program, the Board of Directors authorized the repurchase of up to 1.8 million shares of the Company’s Common Stock through April 30, 2015. The Board of Directors has since extended the program through June 2, 2016 and expanded the maximum number of shares authorized to be repurchased from 1.8 million shares to 3.4 million shares.

Since the commencement of this repurchase plan through June 28, 2015, the Company has repurchased 1,693,609 common shares under this plan for an aggregate dollar amount of $6,572.

				Total Number of Shares Purchased				Average Price Paid Per Share(2)				Total Number of Shares Purchased as Part of Publicly Announced Program				Maximum Number of Shares That May Yet Be Purchased Under the Program(1)
	March 30 – April 26				38,406			$	3.80				38,406				3,066,439
	April 27 – May 24				1,196,761				3.91				1,196,761				1,869,678
	May 25 – June 28				163,287				4.21				163,287				1,706,391
	Total				1,398,454			$	3.94				1,398,454				1,706,391

 

⁽¹⁾April and May share figures have been retroactively adjusted to include 1.6 million share expansion of the share repurchase program approved on June 2, 2015.

⁽²⁾Average Price Paid Per Share excludes fees and commissions related to such repurchases. Including these costs, the average price paid per share for all purchases under the Share Repurchase Program is $3.97.

 

 

ITEM 6. EXHIBITS

 

Exhibit Index	Description of Document		Incorporated By Reference from:
31.1	Rule 13a-14(a) / 15d-14(a) CEO Certifications		Filed herewith
31.2	Rule 13a-14(a) / 15d-14(a) CFO Certifications		Filed herewith
32	Section 1350 Certifications		Filed herewith
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document
101.DEF	XBRL Taxonomy Definition Document

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

		ULTRALIFE CORPORATION
		(Registrant)
	Date: July 30, 2015	By:   /s/  Michael D. Popielec
		Michael D. Popielec
		President and Chief Executive Officer
		(Principal Executive Officer)
	Date: July 30, 2015	By:   /s/  Philip A. Fain
		Philip A. Fain
		Chief Financial Officer and Treasurer
		(Principal Financial Officer and
		Principal Accounting Officer)

 

 

 

 

 

 

Index to Exhibits

 

31.1

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Calculation Linkbase Document

101.LAB

XBRL Taxonomy Label Linkbase Document

101.PRE

XBRL Taxonomy Presentation Linkbase Document

101.DEF

XBRL Taxonomy Definition Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30 

Exhibit 31.1

 

I, Michael D. Popielec, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Ultralife Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	Date: July 30, 2015	By:   /s/ Michael D. Popielec
		Michael D. Popielec
		President and Chief Executive Officer

Exhibit 31.2

 

I, Philip A. Fain, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Ultralife Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

	Date: July 30, 2015	By:   /s/ Philip A. Fain
		Philip A. Fain
		Chief Financial Officer and Treasurer

Exhibit 32

 

 

Section 1350 Certification

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (“Section 906”), Michael D. Popielec and Philip A. Fain, the President and Chief Executive Officer and Chief Financial Officer and Treasurer, respectively, of Ultralife Corporation, certify that (i) the Quarterly Report on Form 10-Q for the quarter ended June 28, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Ultralife Corporation.

 

A signed original of this written statement required by Section 906 has been provided to Ultralife Corporation and will be retained by Ultralife Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

 

	Date: July 30, 2015	By:   /s/ Michael D. Popielec
		Michael D. Popielec
		President and Chief Executive Officer
	Date: July 30, 2015	By:   /s/ Philip A. Fain
		Philip A. Fain
		Chief Financial Officer and Treasurer